Filing Details
- Accession Number:
- 0000950170-25-074496
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-19 16:54:17
- Reporting Period:
- 2025-05-16
- Filing Date:
- 2025-05-19
- Accepted Time:
- 2025-05-19 16:54:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1798749 | Jade Biosciences Inc. | JBIO | Pharmaceutical Preparations (2834) | 831377888 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1823925 | Tom Frohlich | C/O Jade Biosciences, Inc. 221 Crescent St., Bldg. 23, Ste. 105 Waltham MA 02453 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-05-16 | 6,000 | $7.40 | 6,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
